These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15095418)

  • 1. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part II.
    Cerecetto H; González M; Onetto S; Saenz P; Ezpeleta O; De Ceráin AL; Monge A
    Arch Pharm (Weinheim); 2004 May; 337(5):247-58. PubMed ID: 15095418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
    Cerecetto H; González M; Risso M; Saenz P; Olea-Azar C; Bruno AM; Azqueta A; De Ceráin AL; Monge A
    Arch Pharm (Weinheim); 2004 May; 337(5):271-80. PubMed ID: 15095420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
    Monge A; López de Ceráin A; Ezpeleta O; Cerecetto H; Dias E; Di Maio R; González M; Onetto S; Seoane G; Suescun L; Mariezcurrena R
    Pharmazie; 1998 Nov; 53(11):758-64. PubMed ID: 9853357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
    Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA
    J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
    Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
    Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
    J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.
    Urquiola C; Vieites M; Torre MH; Cabrera M; Lavaggi ML; Cerecetto H; González M; Cerain AL; Monge A; Smircich P; Garat B; Gambino D
    Bioorg Med Chem; 2009 Feb; 17(4):1623-9. PubMed ID: 19162490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-selective 3-alkyl 1,2,4-benzotriazine 1,4-dioxides: the influence of hydrogen bond donors on extravascular transport and antitumor activity.
    Hay MP; Pchalek K; Pruijn FB; Hicks KO; Siim BG; Anderson RF; Shinde SS; Phillips V; Denny WA; Wilson WR
    J Med Chem; 2007 Dec; 50(26):6654-64. PubMed ID: 18052317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure and hypoxic cytotoxicity of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
    Jiang F; Weng Q; Sheng R; Xia Q; He Q; Yang B; Hu Y
    Arch Pharm (Weinheim); 2007 May; 340(5):258-63. PubMed ID: 17464965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, hypoxia-selective cytotoxicity of new 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
    Xia Q; Zhang L; Zhang J; Sheng R; Yang B; He Q; Hu Y
    Eur J Med Chem; 2011 Mar; 46(3):919-26. PubMed ID: 21281992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
    Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
    J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Cu(II) quinoxaline N1,N4-dioxide complexes as selective hypoxic cytotoxins.
    Torre MH; Gambino D; Araujo J; Cerecetto H; González M; Lavaggi ML; Azqueta A; López de Cerain A; Vega AM; Abram U; Costa-Filho AJ
    Eur J Med Chem; 2005 May; 40(5):473-80. PubMed ID: 15893021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
    Saczewski F; Bułakowska A
    Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity.
    Lee HH; Wilson WR; Denny WA
    Anticancer Drug Des; 1999 Dec; 14(6):487-97. PubMed ID: 10834270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.
    Solano B; Junnotula V; Marín A; Villar R; Burguete A; Vicente E; Pérez-Silanes S; Aldana I; Monge A; Dutta S; Sarkar U; Gates KS
    J Med Chem; 2007 Nov; 50(22):5485-92. PubMed ID: 17910426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-targeted 1,2,4-benzotriazine 1,4-dioxides: potent analogues of the hypoxia-selective cytotoxin tirapazamine.
    Hay MP; Pruijn FB; Gamage SA; Liyanage HD; Kovacs MS; Patterson AV; Wilson WR; Brown JM; Denny WA
    J Med Chem; 2004 Jan; 47(2):475-88. PubMed ID: 14711317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
    Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
    J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convenient synthesis of fused heterocyclic 1,3,5-triazines from some N-acyl imidates and heterocyclic amines as anticancer and antioxidant agents.
    Bekircan O; Küxük M; Kahveci B; Kolayli S
    Arch Pharm (Weinheim); 2005 Aug; 338(8):365-72. PubMed ID: 16041836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,2,5-Oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs: structure-activity relationships.
    Cerecetto H; Di Maio R; González M; Risso M; Saenz P; Seoane G; Denicola A; Peluffo G; Quijano C; Olea-Azar C
    J Med Chem; 1999 Jun; 42(11):1941-50. PubMed ID: 10354402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
    Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
    Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.